+558.1%
ABBV vs CVNA
+2,520.0%
-1,961.9%
-45.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -2.3% | +2.1% | -0.1% |
| 7D | +0.4% | -7.2% | +7.7% | +0.6% |
| 30D | +3.2% | +20.2% | -17.0% | +2.7% |
| 3M | +18.8% | -6.4% | +25.2% | +18.9% |
| 6M | +41.9% | +5.3% | +36.5% | +41.4% |
| YTD | +32.8% | -16.2% | +49.0% | +32.8% |
| 1Y | +30.6% | +11.1% | +19.4% | +29.6% |
| 3Y | +135.4% | +993.0% | -857.7% | +116.6% |
| 5Y | +202.2% | +17.6% | +184.6% | +199.3% |
| All | +558.1% | +2,520.0% | -1,961.9% | +396.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CVNA.
Daily Out/Under-Performance
Portfolio return minus CVNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling